Which has the lower trailing P/E, PBYI or TCMD?

PBYI has the lower trailing P/E: PBYI trades at 18.40 and TCMD at 20.55. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, PBYI or TCMD?

Over the past five years, TCMD grew revenue faster — PBYI at a 0.29% CAGR versus TCMD at 11.62%.

Is PBYI or TCMD more profitable?

PBYI runs the higher net margin — PBYI at 11.55% versus TCMD at 7.10%.

How have PBYI and TCMD total returns compared?

Over the past 10 years, PBYI delivered -17.43% and TCMD delivered 1.68% annualized total return. Past performance doesn't predict future results.

Puma Biotechnology, Inc. (PBYI) vs Tactile Systems Technology, Inc. (TCMD)

A side-by-side comparison of Puma Biotechnology, Inc. and Tactile Systems Technology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

PBYI

Puma Biotechnology, Inc.

$484M

$9.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TCMD

Tactile Systems Technology, Inc.

$501M

$22.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — PBYI vs TCMD

growth of $100 · dividends reinvested · last 10y

PBYI -85.3% (-17.4%/yr)TCMD +18.1% (+1.7%/yr)TCMD compounded faster over this window

Log scale — wide-divergence pair

PBYI TCMD

PBYI vs TCMD: by the numbers

•TCMD is the larger company ($501M vs $484M market cap).
•PBYI trades at the lower trailing earnings multiple (18.40 vs 20.55 P/E), one valuation lens rather than an overall verdict.
•PBYI converts more revenue to profit (11.55% vs 7.10% net margin).
•TCMD grew revenue faster over the past five years (11.62% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	PBYI	TCMD
P/E ratio	18.40	20.55
Forward P/E	25.00	19.87
P/S ratio	2.09	1.43
P/B ratio	3.49	2.24
EV / EBITDA	10.41	10.66
FCF yield	8.50%	5.34%

Profitability

Metric	PBYI	TCMD
Gross margin	74.83%	74.23%
Operating margin	13.16%	10.00%
Net margin	11.55%	7.10%
ROE	19.28%	11.11%
ROIC	18.26%	9.54%

Growth (annualized)

Metric	PBYI	TCMD
Revenue CAGR (5Y)	0.29%	11.62%
FCF CAGR (5Y)	90.51%	32.09%
Total return CAGR (5Y)	9.26%	-11.73%

Frequently asked

Which has the lower trailing P/E, PBYI or TCMD?: PBYI has the lower trailing P/E: PBYI trades at 18.40 and TCMD at 20.55. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, PBYI or TCMD?: Over the past five years, TCMD grew revenue faster — PBYI at a 0.29% CAGR versus TCMD at 11.62%.
Is PBYI or TCMD more profitable?: PBYI runs the higher net margin — PBYI at 11.55% versus TCMD at 7.10%.
How have PBYI and TCMD total returns compared?: Over the past 10 years, PBYI delivered -17.43% and TCMD delivered 1.68% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PBYI analysis Full TCMD analysis Interactive comparison tool

Dig into the metrics

Puma Biotechnology P/E ratio Tactile Systems Technology P/E ratio Puma Biotechnology ROE Tactile Systems Technology ROE Puma Biotechnology operating margin Tactile Systems Technology operating margin Puma Biotechnology revenue growth Tactile Systems Technology revenue growth Puma Biotechnology free cash flow Tactile Systems Technology free cash flow

Puma Biotechnology & Tactile Systems Technology appear in these rankings

Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.